Ansabot, Jahara .
HRN: 24-99-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/18/2024
05/25/2024
IV
500mg
Now Then Q8
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes